Table 1.
Variables | Values (n = 202) |
---|---|
Age (years), mean (SD) | 50.41 (11.95) |
Albumin (g/L), mean (SD) | 41.39 (3.75) |
WBC (109/L), mean (SD) | 5.63 (1.67) |
Neutrophil (109/L), mean (SD) | 3.46 (1.35) |
Lymphocyte (109/L), mean (SD) | 1.49 (0.54) |
Monocyte (109/L), mean (SD) | 0.48 (0.2) |
PLT (109/L), mean (SD) | 161.72 (69.06) |
Total bilirubin (μmol/L), mean (SD) | 14.94 (12) |
Direct bilirubin (μmol/L), mean (SD) | 5.94 (6.55) |
ALT (U/L), mean (SD) | 43.28 (34.19) |
AST (U/L), mean (SD) | 46.90 (32.98) |
PT (s), mean (SD) | 13.2 (0.98) |
APTT (s), mean (SD) | 33.11 (4.32) |
Tumor diameter (cm), mean (SD) | 5.77 (3.38) |
Creatinine (μmol/L), mean (SD) | 86.55 (16.5) |
PNI | 48.83 (4.8) |
SII | 433.23 (325.61) |
Hospital stay (days), mean (SD) | 15.43 (4.33) |
Gender | |
Male | 168 |
Female | 34 |
HBV | |
Absence | 33 |
Presence | 169 |
Tumor capsular | |
Absence | 142 |
Presence | 60 |
AFP | |
≤ 20 ng/mL | 74 |
> 20 ng/mL | 128 |
Edmondson grade | |
I–II | 152 |
III–IV | 50 |
Tumor number | |
Single | 153 |
Multiple | 49 |
Satellite nodules | |
Absence | 186 |
Presence | 16 |
Cirrhosis | |
Absence | 52 |
Presence | 152 |
BCLC stage | |
0/A | 141 |
B | 40 |
C | 21 |
TNM stage | |
I/II | 167 |
III | 35 |
WBC white blood cell, PLT platelet, ALT alanine transaminase, AST aspartate transaminase, PT prothrombin time, PNI prognostic nutritional index, SII systemic immune-inflammation index, AFP alpha-fetoprotein, BCLC Barcelona Clinic Liver Cancer, TNM tumor-node-metastasis